Nanomedicine for women’s Healthcare


Sustained drug delivery has the prospective to improve the treatment and prevention of many circumstances and diseases that afflict the female reproductive tract. However, achieving effective, therapeutic delivery in the vaginal tract is challenging due to vaginal physiology. To overcome these issues, we are emerging nanomedicines and novel delivery vehicles that can provide sustained release (improving effectiveness) and deliver drugs uniformly to the target surface. Improved local vaginal delivery has promise for preventing preterm birth and sexually transmitted infections, as well as treating bacterial vaginosis and cervical cancer. Confined delivery could not only improve the efficiency of cancer treatment, but also dramatically improve patient quality of life by reducing the side effects associated with systemic chemotherapy. We also use our nanotechnologies to gain fundamental understanding of the factors that lead to infections in the female reproductive tract.



 


    Related Conference of Nanomedicine for women’s Healthcare

    June 23-24, 2025

    38th World Congress on Pharmacology

    Paris, France
    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    September 19-20, 2025

    18th World Drug Delivery Summit

    Paris, France
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    November 13-14, 2025

    21st International Conference on Pharmaceutical Chemistry

    Aix-en-Provence, France
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Paris, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 27-28, 2025

    13th International Conference on Clinical Trials

    Amsterdam, Netherlands
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, Aland Islands
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands

    Nanomedicine for women’s Healthcare Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in